Related content

Conversations with Mike Milken

Ramping Up, with Novartis’s Vasant Narasimhan


As CEO of one of the largest pharmaceutical companies in the world, Vas Narasimhan knows what a unique moment in history this is. That’s why he’s spending hundreds of millions of dollars in research and development to attack COVID-19 from a variety of angles. Among these are protease inhibitors, monoclonal antibodies, and “glue degraders” that help dissolve critical proteins in the virus.

View

For a limited time: Become a Charter Member!